14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:PTLA
Delisted

Portola Pharmaceuticals Stock Signals

$18.03
+0 (+0%)
At Close: Sep 04, 2020

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 88 days ( -132.35 % )
Last Price $18.03 0 %
High/ Low $18.03 - $18.03 0%
Chg 7 Days N/A $18.03 $18.03
Chg 30 Days N/A $18.03 $18.03
Chg 12 mos -37.44 % $28.82 $18.03
Trend - 3 mos 0.600 % Width: 0.486 %
Trend - 12 mos -39.21 % Width: 2,048.49 %
Pred. range - 3 mos $18.11 - $18.20 0.435 % - 0.92 %
Pred. range - 12 mos N/A - $13.80 -100.00 % - -23.46 %
Short MA avg 3 mos Sell Jun 18, 2020 - 56 days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Jun 18, 2020 - 56 days
Long MA avg 12 mos Buy May 04, 2020 - 88 days
Short/Long MA avg 12 mos Buy May 12, 2020 - 82 days
Pivot Short Sell Sep 03, 2020 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Portola Pharmaceuticals

Portola Pharmaceuticals Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics for patients in the areas of thrombosis, other hematologic disorders, and inflammation. The company is developing Betrixaban, an oral, once-daily Factor Xa inhibitor, which is in Phase III clinical trial for treating venous thromboembolism prophylaxis in acute medically ill patients in-hospital and post discharge; and Andexanet alfa, a recombinant... PTLA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT